Skip to main content

Table 1 Clinical characteristics of the patients

From: Serum Levels of sRAGE, the Soluble Form of Receptor for Advanced Glycation End Products, Are Associated with Inflammatory Markers in Patients with Type 2 Diabetes

n 86
Age, years 68.4 ± 9.6
Male sex 36 (41.9)
BMI, kg/m2 24.7 ± 4.1
Waist circumference, cm 90.2 ± 9.3
sRAGE, pg/mL 601.8 ± 477.3
AST, IU/L 22.9 ± 8.0
ALT, IU/L 24.2 ± 17.0
γ-GTP, IU/L 40.7 ± 43.1
Total cholesterol, mg/dL 201.9 ± 32.1
Triglycerides, mg/dL 140.9 ± 73.6
HDL cholesterol, mg/dL 50.2 ± 12.6
LDL cholesterol, mg/dL 130.9 ± 30.5
Creatinine, mg/dL 0.89 ± 0.28
Glucose mg/dL 184.4 ± 76.1
HbA1c, % 7.6 ± 1.4
Systolic BP, mmHg 132.2 ± 10.3
Diastolic BP, mmHg 75.2 ± 7.2
Uric acid, mg/dL 5.0 ±1.4
MCP-1, pg/mL 320.9 ± 95.1
Adiponectin, (g/mL 3.8 ± 3.3
TNF-(, pg/mL 1.16 ±0.66
IL-6, pg/mL 1.89 ± 1.9
Current smoking,  
(% yes) 12 (14)
Alcohol intake,  
(% yes) 25 (29.1)
Diabetes medication 57 (66.3)
Hypertension medication 65 (75.6)
Hyperlipidemia medication 24 (27.9)
  1. Values are n (%) or mean ± SD.